Search

Your search keyword '"Cocaine-Related Disorders diagnosis"' showing total 812 results

Search Constraints

Start Over You searched for: Descriptor "Cocaine-Related Disorders diagnosis" Remove constraint Descriptor: "Cocaine-Related Disorders diagnosis"
812 results on '"Cocaine-Related Disorders diagnosis"'

Search Results

151. Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10.

152. Prenatal cocaine exposure, illicit-substance use and stress and craving processes during adolescence.

153. Self-reported cue-induced physical symptoms of craving as an indicator of cocaine dependence.

154. Approach to the Adolescent with Chest Pain.

155. Retiform Purpura in Plaques.

156. What are the ethical issues in treating a patient with bilateral leg gangrene incapable of consenting to amputation secondary to psychiatric illness?

157. Adaptation of the Monetary Choice Questionnaire to accommodate extreme monetary discounting in cocaine users.

158. iMStrong: Deployment of a Biosensor System to Detect Cocaine Use.

159. Basal Hippocampal Activity and Its Functional Connectivity Predicts Cocaine Relapse.

160. Some of the people, some of the time: field evidence for associations and dissociations between stress and drug use.

161. The DSM-5 and the diagnosis of substance use disorders: Reflection about validity of the new criteria and possible 'missing pieces' in the puzzle.

162. Out-of-hospital cardiac arrest after acute cocaine intoxication associated with Brugada ECG patterns: Insights into physiopathologic mechanisms and implications for therapy.

163. Pyoderma gangrenosum: a possible cutaneous complication of levamisole-tainted cocaine abuse.

164. Childhood trauma are not associated with the intensity of transient cocaine induced psychotic symptoms.

166. Cocaine abuse, retiform purpura and antiphospholipid syndrome.

167. Craniovertebral junction instability as an extension of cocaine-induced midline destructive lesions: case report.

168. Cardiovascular consequences of cocaine use.

169. Treatment of cocaine craving with as-needed nalmefene, a partial κ opioid receptor agonist: first clinical experience.

170. Immediate Hemorrhagic Transformation After Intravenous Tissue-Type Plasminogen Activator Injection in 2 Cocaine Users.

171. Medical diagnoses associated with substance dependence among inpatients at a large urban hospital.

172. The clinical impact of a false-positive urine cocaine screening result on a patient's pain management.

173. CLINICAL PATHOLOGIC CONFERENCE CASE 2: PALATAL PERFORATION.

174. Interactions between the salience and default-mode networks are disrupted in cocaine addiction.

175. Cocaine-induced delayed recurrent vasculitis: a 4-year follow-up.

176. Acute macular neuroretinopathy following intranasal use of cocaine.

177. Chronic and recreational use of cocaine is associated with a vulnerability to semantic interference.

178. Screening and brief intervention for substance misuse: Does it reduce aggression and HIV-related risk behaviours?

179. Early abstinence of crack-cocaine is effective to attenuate oxidative stress and to improve antioxidant defences.

180. Sensation seeking and cocaine dependence in adults with reported childhood ADHD.

181. Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: a comprehensive narrative overview of English-language studies.

182. Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidity.

183. Significance of alanine aminotransferase levels in patients admitted for cocaine intoxication.

184. Interpretation of urine analysis for cocaine metabolites.

185. Fixed-drug reaction secondary to cocaine use.

186. Effects of cocaine-positive urine screens on serum thyrotropin levels in patients admitted to an inpatient mental health unit.

187. Reliability and validity of the Spanish version of the substance dependence severity scale.

188. The Prevalence of Posttraumatic Stress Disorder Symptoms among Addiction Treatment Patients with Cocaine Use Disorders.

189. Possibilities for discrimination between chewing of coca leaves and abuse of cocaine by hair analysis including hygrine, cuscohygrine, cinnamoylcocaine and cocaine metabolite/cocaine ratios.

190. Validation of the cocaine versions of the Obsessive Compulsive Drug Use Scale and the Desires for Drug Questionnaire.

191. Genetic and toxicologic investigation of Sudden Cardiac Death in a patient with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) under cocaine and alcohol effects.

192. Cocaine-induced agitated delirium: a case report and review.

193. Assessing Drug Consumption Behavior With the Heidelberger Drogenbogen (Heidelberg Drug Scales): Reliabilities, Validities, and Cut-Off Criteria.

194. Assessing cocaine abuse using LC-MS/MS measurements in biological specimens.

195. A randomized, controlled trial of combined cognitive-behavioral therapy plus prize-based contingency management for cocaine dependence.

196. It is not just memory: propositional thinking influences performance on the autobiographical IAT.

197. Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages.

198. Altered neural correlates of reward and loss processing during simulated slot-machine fMRI in pathological gambling and cocaine dependence.

199. Gender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiram.

200. A direct immersion solid-phase microextraction gas chromatography/mass spectrometry method for the simultaneous detection of levamisole and minor cocaine congeners in hair samples from chronic abusers.

Catalog

Books, media, physical & digital resources